Subscribe to the Legendary Newsletter
A list of candidates (like Chime or Revolut) and their recent profit margins?
A nuclear reactor manufacturer that debuted on the Nasdaq in April 2026 with a valuation of roughly $11.9 billion. Its IPO was significantly oversubscribed, reflecting strong appetite for energy infrastructure. recent ipos to buy
Leading GenAI firms rumored to be weighing public debuts this year. A list of candidates (like Chime or Revolut)
Valued at roughly $134 billion; a leader in data and AI platforms. recent ipos to buy
A payments processing leader with a private valuation near $159 billion. To help you decide which IPOs fit your portfolio,
Analysis of IPOs with upcoming clinical trial milestones?
Healthcare biotech; currently trading ~47% above its initial offering.